FIRST AMENDMENT TO LOAN AGREEMENTLoan Agreement • February 9th, 2021 • Urovant Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThis First Amendment to Loan Agreement, dated as of February 5, 2021 (this “Amendment”), is between Sumitomo Dainippon Pharma Co., Ltd., a company (Kabushiki Kaisha) incorporated under the laws of Japan (the “Lender”), and Urovant Sciences Ltd., an exempted company organized under the laws of Bermuda (the “Borrower” and, together with the Lender, the “Parties” and each, a “Party”).